Genscript Biotech

Update in progress

1548.HK (HKSE)

Company RatingNeutral
SectorHealthcare
IndustryBiotechnology

Genscript Biotech Corporation is an investment holding company that manufactures and sells life-science products and services worldwide. It operates in three segments: Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products. It offers gene, oligo and peptide synthesis, protein engineering, antibody development, and lab tools; supports biologics and gene/cell therapies; and develops industrial enzymes from engineered microbes. Founded 2002, based in Nanjing, PRC.

Company score

Sentiment: 0.31; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.00; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.26; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.06; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.13; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive